Livzon Pharmaceutical Group Inc.
000513
주식 순위
#4689
Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and... Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and established in 1985, is a biopharmaceutical enterprise operating across the entire spectrum of pharmaceutical activities, from research and development to manufacturing and commercialization. The company's operations encompass a diverse range of finished drug products, active pharmaceutical ingredients (APIs), and chemical intermediates, primarily serving the Chinese market while also engaging in international exports. Its pharmaceutical portfolio includes treatments such as Ilaprazole enteric coated tablets for duodenal ulcers and reflux esophagitis, Laprazole sodium injection for managing peptic ulcer bleeding, Leuprorelin Acetate Microspheres for injection, and Urofollitropin injection for anovulation and fertility support. Livzon also produces Perospirone Hydrochloride for schizophrenia, Anti-viral Granules targeting upper respiratory tract infections and influenza, and Shenqi Fuzheng Injection, which addresses general weakness, fatigue, spontaneous sweating, and vertigo, and provides supportive care for lung and stomach cancer patients. Beyond therapeutic drugs, Livzon Pharmaceutical Group develops and distributes a variety of diagnostic reagents. These include kits for detecting IgM/IgG antibodies to coronavirus, nucleic acid tests for human immunodeficiency virus type 1, antinuclear antibody test kits, interferon-gamma release assay kits, and rapid tests for mycoplasma pneumoniae IgM antibodies. The company's extensive offerings further extend to biochemical drugs, microbiological preparations, biologics, traditional Chinese medicine formulations, pharmaceutical raw materials, and antibiotics.
주가
$3.90
시가총액
$3.17B
변동 (1일)
-3.49%
변동 (1년)
-25.88%
국가
CN
거래 Livzon Pharmaceutical Group Inc. (000513)
카테고리
Healthcare
Livzon Pharmaceutical Group Inc. (000513)의 수익
Jun 2026 기준 수익 TTM: $353.39M
Livzon Pharmaceutical Group Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익은 $353.39M입니다. 2024년에 회사는 $384.45M의 수익을 올렸으며 이는 2023년의 수익 $336.60M과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Livzon Pharmaceutical Group Inc.의 수익 기록 (2001 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $353.39M | -13.61% |
| 2025 | $409.07M | 6.40% |
| 2024 | $384.45M | 14.22% |
| 2023 | $336.60M | -0.37% |
| 2022 | $337.86M | -4.38% |
| 2021 | $353.32M | -7.28% |
| 2020 | $381.07M | 53.60% |
| 2019 | $248.09M | 20.46% |
| 2018 | $205.95M | -76.59% |
| 2017 | $879.92M | 507.84% |
| 2016 | $144.76M | 16.35% |
| 2015 | $124.42M | 18.19% |
| 2014 | $105.27M | 1.52% |
| 2013 | $103.69M | 15.39% |
| 2012 | $89.85M | 22.30% |
| 2011 | $73.47M | -9.13% |
| 2010 | $80.85M | -6.35% |
| 2009 | $86.33M | 457.58% |
| 2008 | $15.48M | -81.76% |
| 2007 | $84.91M | 200.91% |
| 2006 | $28.22M | 72.44% |
| 2005 | $16.36M | -12.46% |
| 2004 | $18.69M | -1.91% |
| 2003 | $19.06M | 40.37% |
| 2002 | $13.58M | 11.75% |
| 2001 | $12.15M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $3.62B | 923.75% |
DE
|
|
| $3.40B | 863.51% |
DE
|
|
| $1.72B | 387.73% |
JP
|
|
| $930.30M | 163.25% |
CH
|
|
| $1.69B | 378.97% |
IN
|
